Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man.
Article Details
- CitationCopy to clipboard
Stockler S, Isbrandt D, Hanefeld F, Schmidt B, von Figura K
Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man.
Am J Hum Genet. 1996 May;58(5):914-22.
- PubMed ID
- 8651275 [ View in PubMed]
- Abstract
In two children with an accumulation of guanidinoacetate in brain and a deficiency of creatine in blood, a severe deficiency of guanidinoacetate methyltransferase (GAMT) activity was detected in the liver. Two mutant GAMT alleles were identified that carried a single base substitution within a 5' splice site or a 13-nt insertion and gave rise to four mutant transcripts. Three of the transcripts encode truncated polypeptides that lack a residue known to be critical for catalytic activity of GAMT. Deficiency of GAMT is the first inborn error of creatine metabolism. It causes a severe developmental delay and extrapyramidal symptoms in early infancy and is treatable by oral substitution with creatine.